BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 17132578)

  • 1. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based interventions and alcohol, tobacco and other drugs: foci, outcomes and implications.
    Giesbrecht N; Haydon E
    Drug Alcohol Rev; 2006 Nov; 25(6):633-46. PubMed ID: 17132579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments.
    Spicer N; Harmer A; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Soc Sci Med; 2011 Dec; 73(12):1748-55. PubMed ID: 22036298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting health and preventing disease: an international perspective on youth health promotion.
    Nutbeam D
    J Adolesc Health; 1997 May; 20(5):396-402. PubMed ID: 9168387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the insidious health and financial burden of tobacco use in Missouri: the role of medical and public health professionals.
    Everett KD; Bullock L; Longo DR
    Mo Med; 2006; 103(2):175-9. PubMed ID: 16703720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco and cancer: an American Association for Cancer Research policy statement.
    Viswanath K; Herbst RS; Land SR; Leischow SJ; Shields PG;
    Cancer Res; 2010 May; 70(9):3419-30. PubMed ID: 20388799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Political economy of tobacco control policy on public health in Japan.
    Desapriya EB; Iwase N; Shimizu S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):15-33. PubMed ID: 12687722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action plan for a tobacco-free Europe: implementation in central and eastern Europe, 1993-94. WHO Regional Office for Europe.
    Eur J Cancer Prev; 1993 Mar; 2(2):117-23. PubMed ID: 8461862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing tobacco harm: research challenges and issues.
    Hatsukami DK; Slade J; Benowitz NL; Giovino GA; Gritz ER; Leischow S; Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S89-101. PubMed ID: 12573171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of human parasitic diseases: Context and overview.
    Molyneux DH
    Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement update: tobacco control--reducing cancer incidence and saving lives. 2003.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jul; 21(14):2777-86. PubMed ID: 12777442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current tobacco control policy trends in the United States.
    Stoner WI; Foley BX
    Clin Occup Environ Med; 2006; 5(1):85-99, ix. PubMed ID: 16446256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in international tobacco control.
    Thompson F; Fagerström K
    Clin Occup Environ Med; 2006; 5(1):101-16, ix. PubMed ID: 16446257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Tobacco Control Program: focusing on policy to broaden impact.
    Wisotzky M; Albuquerque M; Pechacek TF; Park BZ
    Public Health Rep; 2004; 119(3):303-10. PubMed ID: 15158109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has global fund support for civil society advocacy in the former Soviet Union established meaningful engagement or 'a lot of jabber about nothing'?
    Harmer A; Spicer N; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Health Policy Plan; 2013 May; 28(3):299-308. PubMed ID: 22767433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying an equity lens to tobacco-control policies and their uptake in six Western-European countries.
    Giskes K; Kunst AE; Ariza C; Benach J; Borrell C; Helmert U; Judge K; Lahelma E; Moussa K; Ostergren PO; Patja K; Platt S; Prättälä R; Willemsen MC; Mackenbach JP
    J Public Health Policy; 2007 Jul; 28(2):261-80. PubMed ID: 17585326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.